St Guanfu: the controlling shareholder and its related parties intend to increase their shareholding of the company by RMB 100million to RMB 200million
St Guanfu announced that the total amount of shares to be increased by the controlling shareholder of the company, Chengfa capital and Chengfa construction, Tongcheng real estate, Jingfang investment, Tongxiang investment, Chengtong investment, Chengfa property, Chengjia construction, Xinsheng investment, urban operation and municipal construction (including the amount of this increase) is not less than 100million yuan and not more than 200million yuan.
This text is a result of machine translation.
Related companies：
Briefing Jun 22, 2022 03:39 PM
· Technology
The first batch of centralized land supply transactions in Zhengzhou were 15 plots, with a transaction amount of 10.674 billion yuan
In-depth
Technology, AI
China’s E-bike Brands Going Global: A Review of 26 Leading Players
With the global e-bike market continuing to expand, Chinese e-bike companies are gradually shifting from being a manufacturing powerhouse to becoming a meaningful force in global competition. This article reviews a group of Chinese e-bike players and examines their overseas positioning and market entry paths—looking at how Chinese brands are securing a foothold in the next wave of globalization.
Dec 19, 2025 02:56 PM
Briefing Jun 20, 2022 11:04 PM
The Central Committee decided that wangyonghong would be appointed secretary of the leading Party group and director general of the state organ affairs administration
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Nov 16, 2022 05:19 PM
Briefing May 27, 2022 07:54 PM
· Technology
Excess PV silicon? Industry: the development of large-size silicon wafers exceeds expectations, and the supply is still tight
Briefing May 27, 2022 06:18 PM
· Healthcare
Declaration of the first affordable rental housing REITs
Healthcare
Kanghong’s Conbercept Receives Marketing Authorization in Guyana
Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).
Yesterday 02:48 PM
Consumer Staples
SHEIN Reportedly Targets US$26–27 Billion Valuation in Hong Kong IPO
SHEIN (希音), the China-founded global fashion and lifestyle retailer, is reportedly seeking a valuation of US$26 billion to US$27 billion in a planned Hong Kong initial public offering, a sharp reduction from the US$98.2 billion private-market valuation disclosed for its 2022 fundraising round.
Yesterday 02:02 PM
Briefing May 17, 2022 02:30 PM
· Technology
Zhao Dachun, deputy general manager of China Mobile: ensure that more than one million 5g base stations are opened before the 20th CPC National Congress
Technology
China Mobile Returns to A-share Market Planning to Issue 965 Mn Shares
The announcement shows that the funds raised by the telecommunication company will be used for projects such as 5G boutique network construction, new Cloud infrastructure construction, gigabit smart home construction, new-generation information technology research and development, digital intelligence ecology construction, and so on.
May 18, 2021 11:28 AM
Briefing Apr 24, 2022 12:05 PM
Report: domestic game revenue in the first quarter increased by 3% year-on-year, lower than the same period last year
Briefing Apr 02, 2022 05:34 PM
· Technology
China network security industry innovation and development alliance was officially established
See more
Read next
Insight
In-depth
Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors
Aug 04, 2026 11:21 AM
Insight
In-depth
Low-altitude Economy · Interview
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 31, 2026 02:44 PM